Compare ORGO & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORGO | HIO |
|---|---|---|
| Founded | 1985 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.8M | 349.0M |
| IPO Year | 2016 | N/A |
| Metric | ORGO | HIO |
|---|---|---|
| Price | $2.52 | $3.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 937.0K | 346.4K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.33% |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.04 | $3.52 |
| 52 Week High | $7.08 | $4.05 |
| Indicator | ORGO | HIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 41.82 |
| Support Level | $2.20 | $3.53 |
| Resistance Level | $2.67 | $3.70 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 62.12 | 20.83 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.